Old Web
English
Sign In
Acemap
>
authorDetail
>
Av Pino
Av Pino
Novartis
Inhalation
Inhaler
Physical therapy
COPD
Medicine
4
Papers
30
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Patient perception of Breezhaler® and Ellipta® device feedback mechanisms in COPD: The ADVANTAGE Study
2019
Current Medical Research and Opinion
Pablo Altman
Miguel Bergna
Gabriel Garcia
Tadhg Guerin
Av Pino
John L. Whiteford
Show All
Source
Cite
Save
Citations (4)
Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial
2018
BMC Pulmonary Medicine
Pablo Altman
Luis Wehbe
Juergen Dederichs
Tadhg Guerin
Brian Ament
Miguel Cardenas Moronta
Av Pino
Pankaj Goyal
Show All
Source
Cite
Save
Citations (25)
P221 Comparing the perception of feed-back mechanism of the breezhaler® device with the ellipta® device in patients with chronic obstructive pulmonary disease (COPD): the advantage study
2016
Thorax
Pablo Altman
Miguel Bergna
Gabriel Garcia
Konstantinos Kostikas
Tadhg Guerin
Av Pino
J Whiteford
Show All
Source
Cite
Save
Citations (0)
P288 Copd patients with varying severity of airflow limitation achieve highest peak inspiratory flow rate via the breezhaler® inhaler compared to the ellipta® or the handihaler® dry powder inhalers
2016
Thorax
Pankaj Goyal
Luis Wehbe
Juergen Dederichs
Tadhg Guerin
Mc Moronta
Av Pino
Konstantinos Kostikas
Pablo Altman
Show All
Source
Cite
Save
Citations (1)
1
map